Exemestane, CAS 107868-30-4 Sole GMP Manufacturer
Exemestane, CAS 107868-30-4 stable novel crystalline or amorphous form both we have, Exemestane, CAS 107868-30-4no any IP problem. Exemestane, CAS 107868-30-4 DMF filling, free sample of Exemestane, CAS 107868-30-4.
EOS Med Chem have already carried out Exemestane, CAS 107868-30-4 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Exemestane, CAS 107868-30-4 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is Exemestane, CAS 107868-30-4 Intermeidates list, most from GMP plant:
| Exemestane, CAS 107868-30-4 Intermediate 19457-55-7, stock 9.3kg, assay 98.9%, White powder. |
| Exemestane, CAS 107868-30-4 Intermediate 897-06-3, stock 4.6kg, assay 98.8%, White powder. |
| Exemestane, CAS 107868-30-4 Intermediate 123-75-1, stock 7.6kg, assay 98.2%, White powder. |
| Exemestane, CAS 107868-30-4 Intermediate 67737-88-6, stock 8.3kg, assay 98.3%, White powder. |
| Exemestane, CAS 107868-30-4 Intermediate 184972-09-6, stock 7.1kg, assay 98.5%, White powder. |
| Exemestane, CAS 107868-30-4 Intermediate 1100-17-0, stock 4.4kg, assay 98.5%, White powder. |
| Exemestane, CAS 107868-30-4 Intermediate 1160599-91-6, stock 5kg, assay 98.3%, White powder. |
| Exemestane, CAS 107868-30-4 Intermediate 122370-91-6, stock 7.1kg, assay 98.3%, White powder. |
Exemestane, CAS 107868-30-4 HNMR, MASS, COA, MSDS we have.
Exemestane, CAS 107868-30-4, free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
